Skip to content

A comparison of peritoneal transport in patients with psoriasis and uremia

A comparison of peritoneal transport in patients with psoriasis and uremia 1

Nephron. 1981;29(3-4):185-9. A comparison of peritoneal transport in patients with psoriasis and uremia. Rubin J, Rust P, Brown P, Popovich RP, Nolph KD. Accepted: March 19, 1980. Nephron 1981;29:185-189. A Comparison of Peritoneal Transport in Patients with. Psoriasis and Uremia. J. Jack. Rubin. P. Philip. A comparison of peritoneal transport in patients with psoriasis and uremia.

The epidemiology, clinical manifestations, and treatment of guttate psoriasis will be reviewed here 2Uremic PD patients showed faster peritoneal transport rates for urate, phosphate, and total protein than those in a small number of patients without kidney failure who were treated with PD because of psoriasis (10). Comparison of Kidney Function of the Groups at the End of the Experiment Period. Protein loss induced by complement activation during peritoneal dialysis. A variable loss of macromolecules during peritoneal dialysis has been noted in both humans and experimental animals. A comparison of peritoneal transport in patients with psoriasis and uremia. Molecular mechanisms involved in the peritoneal membrane exposed to peritoneal dialysis. KD: A comparison of peritoneal transport in patients with psoriasis and uremia.

A comparison of peritoneal transport in patients with psoriasis and uremia. Uremic rats were characterized by a higher peritoneal permeability for small solutes and an increased NOS activity due to the up-regulation of endothelial and neuronal NOS. KD: A comparison of peritoneal transport in patients with psoriasis and uremia. Patients starting peritoneal dialysis (PD) vary significantly in peritoneal small solute transport rate (PSTR). A comparison of peritoneal transport in patients with psoriasis and uremia.

Induction Of Chronic Kidney Failure In A Long-term Peritoneal Exposure Model In The Rat: Effects On Functional And Structural Peritoneal Alterations

Peritoneal solute transport progressively increases with time on PD, enhances the dissipation of the osmotic gradient and, eventually, reduces ultrafiltration capacity. A comparison of peritoneal transport in patients with psoriasis and uremia. There is no specific time for the onset of uremia for people with progressive loss of kidney function. 3 Urea could be the precursor of more toxic molecules but its more likely that damage done to the body is from a combination of different compounds which may act as enzyme inhibitors or dereange membrane transport. In 1976 McEvoy and Kelly reported that a uremic patient with psoriasis experienced clearing of skin lesions while being treated with hemodialysis 44. Lymphatic/Immune System Involvement: The lymphatic/immune system is a likely channel by which the pathogens are absorbed and transported for elimination through the skin. Only a few therapeutic trials on patients with uremia with RLS have been published, and there is insufficient scientific evidence to favor any specific therapeutic regimen for uremic-associated RLS. Resection of the blue stained areas revealed endometriosis by SEM and loss of peritoneal cell-cell contact compared to normal, non-staining peritoneum. Flux data obtained with radiotracer protocols can help elucidate the capacity, mechanism, regulation, and energetics of transport systems for specific mineral nutrients or toxicants, and can provide insight into compartmentation and turnover rates of subcellular mineral and metabolite pools. The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis. Management of chronic uremia in elderly patients presents several clinic and organizational difficulties. Differences in Coagulation Between Hemodialysis and Peritoneal Dialysis.

New Insights In The Molecular Mechanisms Regulating Peritoneal Permeability